Literature DB >> 9771570

Quantification of the extraction fraction for gadopentetate across breast cancer capillaries.

H E Daldrup1, D M Shames, W Husseini, M F Wendland, Y Okuhata, R C Brasch.   

Abstract

To quantify the extraction fraction, E, for gadopentetate across tumor capillaries, R3230 adenocarcinomas were implanted in the mammary fat pads of seven rats. The value of E was determined by using a two-compartment tissue model in which the endothelial transfer coefficient, K(PS) (ml x min(-1) x cc(-1) of tissue), was estimated from the model fitted to changes in R1 relaxation time (deltaR1; s(-1)) measured by dynamic three-dimensional spoiled gradient recalled magnetic resonance imaging after injection of 0.1 mmol x kg(-1) of gadopentetate dimeglumine. The plasma flow rate through the tumor capillaries, Fp, (ml x min(-1) x g(-1) of tissue), was independently measured with fluorescent microspheres. E could be calculated by the relationship, E = K(PS)/Fp. The mean E for gadopentetate in the R3230 tumor was 0.197 +/- 0.118 with a range of 0.123-0.454. The relatively small mean value of E for gadopentetate allows a fair approximation of the permeability surface area product by K(PS) in this R3230 tumor model.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9771570     DOI: 10.1002/mrm.1910400406

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  15 in total

1.  Comprehensive model for simultaneous MRI determination of perfusion and permeability using a blood-pool agent in rats rhabdomyosarcoma.

Authors:  Cedric de Bazelaire; Nathalie Siauve; Laure Fournier; Frederique Frouin; Philippe Robert; Olivier Clement; Eric de Kerviler; Charles Andre Cuenod
Journal:  Eur Radiol       Date:  2005-08-23       Impact factor: 5.315

2.  In vivo detection of the effects of preconditioning on LNCaP tumors by a TNF-α nanoparticle construct using MRI.

Authors:  Isabelle Iltis; Jeunghwan Choi; Manda Vollmers; Mithun Shenoi; John Bischof; Gregory J Metzger
Journal:  NMR Biomed       Date:  2014-07-01       Impact factor: 4.044

3.  Nanoparticle delivered vascular disrupting agents (VDAs): use of TNF-alpha conjugated gold nanoparticles for multimodal cancer therapy.

Authors:  Mithun M Shenoi; Isabelle Iltis; Jeunghwan Choi; Nathan A Koonce; Gregory J Metzger; Robert J Griffin; John C Bischof
Journal:  Mol Pharm       Date:  2013-04-17       Impact factor: 4.939

4.  Effects of flip angle uncertainty and noise on the accuracy of DCE-MRI metrics: comparison between standard concentration-based and signal difference methods.

Authors:  Ping Wang; Yiqun Xue; Xia Zhao; Jiangsheng Yu; Mark Rosen; Hee Kwon Song
Journal:  Magn Reson Imaging       Date:  2014-10-13       Impact factor: 2.546

5.  Quantitative MR characterization of disease activity in the knee in children with juvenile idiopathic arthritis: a longitudinal pilot study.

Authors:  Dagnachew W Workie; T Brent Graham; Tal Laor; Akila Rajagopal; Kendall J O'Brien; Wendy A Bommer; Judy M Racadio; Norah J Shire; Bernard J Dardzinski
Journal:  Pediatr Radiol       Date:  2007-03-31

6.  Magnetic resonance imaging for monitoring the effects of thalidomide on experimental human breast cancers.

Authors:  Clemens C Cyran; Barbara Sennino; Bundit Chaopathomkul; Yanjun Fu; Victor S Rogut; David M Shames; Michael F Wendland; Donald M McDonald; Robert C Brasch
Journal:  Eur Radiol       Date:  2008-07-30       Impact factor: 5.315

7.  Magnetic resonance imaging assays for dimethyl sulfoxide effect on cancer vasculature.

Authors:  Clemens C Cyran; Barbara Sennino; Bundit Chaopathomkul; Yanjun Fu; Victor Rogut; David M Shames; Michael F Wendland; Donald M McDonald; Robert C Brasch
Journal:  Invest Radiol       Date:  2008-05       Impact factor: 6.016

Review 8.  Clinical biomarkers of angiogenesis inhibition.

Authors:  Aaron P Brown; Deborah E Citrin; Kevin A Camphausen
Journal:  Cancer Metastasis Rev       Date:  2008-09       Impact factor: 9.264

9.  In vivo monitoring of angiogenesis inhibitory treatment effects by dynamic contrast-enhanced computed tomography in a xenograft tumor model.

Authors:  Hans-Juergen Raatschen; Yanjun Fu; Robert C Brasch; Hubertus Pietsch; David M Shames; Benjamin M Yeh
Journal:  Invest Radiol       Date:  2009-05       Impact factor: 6.016

10.  Vascular permeability during antiangiogenesis treatment: MR imaging assay results as biomarker for subsequent tumor growth in rats.

Authors:  Hans-Juergen Raatschen; Gerhard H Simon; Yanjun Fu; Barbara Sennino; David M Shames; Michael F Wendland; Donald M McDonald; Robert C Brasch
Journal:  Radiology       Date:  2008-03-27       Impact factor: 11.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.